Birds (fattening, laying, breeding or show birds): 0.5 ml
No FDA status Not FDA-approved Compound AOD-9604 Mechanism Modified GH fragment
Later studies expanded into cell, tissue, and animal models involving gastrointestinal tissue, tendon, muscle, vascular responses, and other experimental systems
SAFETY AND RESEARCH Preclinical studies : Most of the research on BPC-157 has been conducted in animal models, showing promising results related to soft tissue integrity, as well as other system-specific support such as the gut-brain axis, the detoxification capabilities within the liver, and even neurotransmitter balance

Indications and Usage for B-12 Compliance Injection Cyanocobalamin is indicated for vitamin B12 deficiencies due to malabsorption which may be associated with the following conditions: Addisonian (pernicious) anemia Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy Fish tapeworm infestation Malignancy of pancreas or bowel Folic acid deficiency It may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see DRUG INTERACTION), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue